Tags

Type your tag names separated by a space and hit enter

Sidelining safety--the FDA's inadequate response to the IOM.
N Engl J Med. 2007 Sep 06; 357(10):960-3.NEJM

Links

Publisher Full Text
nejm.org
nejm.org
Aggregator Full Text

Authors+Show Affiliations

Smith SW
Center on Drugs and Public Policy, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, USA.

MeSH

Drug ApprovalDrug-Related Side Effects and Adverse ReactionsGovernment RegulationModels, OrganizationalNational Academies of Science, Engineering, and Medicine, U.S., Health and Medicine DivisionOrganizational InnovationProduct Surveillance, PostmarketingUnited StatesUnited States Food and Drug Administration

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17804840

Citation

Smith, Sheila Weiss. "Sidelining Safety--the FDA's Inadequate Response to the IOM." The New England Journal of Medicine, vol. 357, no. 10, 2007, pp. 960-3.
Smith SW. Sidelining safety--the FDA's inadequate response to the IOM. N Engl J Med. 2007;357(10):960-3.
Smith, S. W. (2007). Sidelining safety--the FDA's inadequate response to the IOM. The New England Journal of Medicine, 357(10), 960-3.
Smith SW. Sidelining Safety--the FDA's Inadequate Response to the IOM. N Engl J Med. 2007 Sep 6;357(10):960-3. PubMed PMID: 17804840.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sidelining safety--the FDA's inadequate response to the IOM. A1 - Smith,Sheila Weiss, PY - 2007/9/7/pubmed PY - 2007/9/11/medline PY - 2007/9/7/entrez SP - 960 EP - 3 JF - The New England journal of medicine JO - N Engl J Med VL - 357 IS - 10 SN - 1533-4406 UR - https://www.unboundmedicine.com/medline/citation/17804840/Sidelining_safety__the_FDA's_inadequate_response_to_the_IOM_ L2 - https://www.nejm.org/doi/10.1056/NEJMp078157?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -